Simplex Trading’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-600
| Closed | -$3K | – | 8701 |
|
|
2019
Q4 | $3K | Buy |
+600
| New | +$3.47K | ﹤0.01% | 6933 |
|
|
2018
Q4 | – | Sell |
-17,239
| Closed | -$48.7K | – | 8280 |
|
|
2018
Q3 | $63K | Buy |
17,239
+17,061
| +9,585% | +$50.8K | ﹤0.01% | 4944 |
|
|
2018
Q2 | $0 | Sell |
178
-27,785
| -99% | -$94.6K | ﹤0.01% | 8176 |
|
|
2018
Q1 | $103K | Buy |
27,963
+24,330
| +670% | +$79.6K | ﹤0.01% | 1783 |
|
|
2017
Q4 | $10K | Buy |
3,633
+3,202
| +743% | +$11.6K | ﹤0.01% | 3936 |
|
|
2017
Q3 | $1K | Buy |
+431
| New | +$1.91K | ﹤0.01% | 5691 |
|
|
2017
Q2 | – | Sell |
-3,271
| Closed | -$13.1K | – | 7179 |
|
|
2017
Q1 | $13K | Buy |
+3,271
| New | +$13.6K | ﹤0.01% | 3752 |
|
|
2016
Q4 | – | Sell |
-32,439
| Closed | -$172K | – | 6880 |
|
|
2016
Q3 | $262K | Buy |
32,439
+15,430
| +91% | +$131K | 0.02% | 855 |
|
|
2016
Q2 | $132K | Buy |
17,009
+11,116
| +189% | +$95.4K | 0.01% | 1280 |
|
|
2016
Q1 | $45K | Sell |
5,893
-21,960
| -79% | -$161K | ﹤0.01% | 2048 |
|
|
2015
Q4 | $300K | Buy |
+27,853
| New | +$253K | 0.02% | 644 |
|
|
2015
Q3 | – | Sell |
-980
| Closed | -$7.98K | – | 6529 |
|
|
2015
Q2 | $8K | Sell |
980
-9,852
| -91% | -$93.2K | ﹤0.01% | 3306 |
|
|
2015
Q1 | $106K | Sell |
10,832
-5,934
| -35% | -$74.1K | 0.01% | 1070 |
|
|
2014
Q4 | $205K | Buy |
+16,766
| New | +$205K | 0.02% | 593 |
|
Simplex Trading's ACHN Position: Q1 2020 in Review
Simplex Trading sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 600 shares — an estimated $3K sold.
Simplex Trading first reported a position in ACHN in Q4 2014 and held it in 14 quarters. The position peaked at $300K in Q4 2015. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Simplex Trading reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Simplex Trading sold 600 Achillion Pharmaceuticals shares in Q1 2020, an estimated $3K.
- Simplex Trading first reported a position in Achillion Pharmaceuticals in Q4 2014 and held it in 14 quarters.
- Simplex Trading's Achillion Pharmaceuticals position peaked at $300K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Simplex Trading's 13F filing for Q1 2020, filed 29 Apr 2020.